A Look At BioMarin Pharmaceutical (BMRN) Valuation As Guidance Rises And New VOXZOGO Data Emerges
BioMarin Pharmaceutical Inc BMRN
$51.81
▼ -2.69%
($-1.43)
Open
$53.41
Prev Close
$53.24
Day Range
$51.68 – $53.41
52W Range
$50.76 – $66.28
Market Cap
$10.01B
P/E (TTM)
37.26
Beta
0.22
EPS (TTM)
$1.35
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1999-07-23 |
| Shares Out. | 192,320,000 |
| Website | biomarin.com/ ↗ |
| Phone | 14155066700 |
BioMarin Pharmaceutical Inc is a publicly traded company under the ticker symbol BMRN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
32 analysts (2026-05-01)
📰 Latest News for BMRN
BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
Evercore ISI Lifts PT on BioMarin Pharmaceutical Inc. (BMRN)
Dell downgraded, Uber upgraded: Wall Street's top analyst calls
Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy’s, and More
Goldman Sachs Reinstates Neutral on BioMarin Pharmaceutical, Announces $69 Price Target
Canaccord Genuity Maintains Buy on BioMarin Pharmaceutical, Raises Price Target to $116